Letters by company

Prosus

1 letter discussing PROSF. Everything written about it on this site is on its ticker page.

FPA Crescent Fund FPA Crescent Fund 2Q26 Commentary FPA Crescent Fund scaled back exposure to AI and data-center beneficiaries as valuations and capital-cycle risks left little margin of safety. It added 14 largely AI-agnostic mid-cap businesses, including specialty chemical distribution and biotech equipment companies, seeking durable growth, strong balance sheets and conservative valuation support. 2Q26 +7.1% 028260 $47BADI $180BNTDOF $62BNVDA $5.1T